Medically Complex Living Donors: Candidacy, Care, and Informed Consent
Tuesday, February 17, 2015 - 14:00
David Serur, MD • New York Presbyterian Weill Cornell
Elisa Gordon, PhD, MPH • Northwestern University
Catherine Garvey, RN, BA, CCTC • University of Minnesota Health
Free to AST members: $25 fee is waived upon logging in during the checkout process.
The long-term acceptance of living donor transplantation has been based on a combination of excellent recipient outcomes and belief that in actuarial terms, there is no increased risk of living with one kidney. However, recent studies have raised controversy and concerns regarding the long-term risks of CKD in kidney donors. How do we interpret these findings? How do we evaluate and when do we clear donors with pre-existing medical conditions like hypertension, obesity, kidney stones, etc., and convey divergent opinions to patients? Comprehensive donor consent remains at the core of this process. Though perceived as challenging existing assumptions, the disclosure of new data will enable a better understanding of the risks so that potential living donors can make a more meaningful, informed decision.
After participating in this webinar, the learner will be able to:
- Distinguish between 'low risk donors' and medically complex living donors
- Evaluate the meanings of new studies regarding donor risk
- Refine the current informed consent process in light of the evolving data
Presenter:
David Serur; Elisa Gordon
Session ID:
299
Identification code:
WEB150217
Prolibraries code:
da04215308f7e65bb7ebb2a93dc5fea4
Description:
The long-term acceptance of living donor transplantation has been based on a combination of excellent recipient outcomes and belief that in actuarial terms, there is no increased risk of living with one kidney. However, recent studies have raised controversy and concerns regarding the long-term risks of CKD in kidney donors. How do we interpret these findings? How do we evaluate and when do we clear donors with pre-existing medical conditions like hypertension, obesity, kidney stones, etc., and convey divergent opinions to patients? Comprehensive donor consent remains at the core of this process. Though perceived as challenging existing assumptions, the disclosure of new data will enable a better understanding of the risks so that potential living donors can make a more meaningful, informed decision.
Objectives:
- Distinguish between “low risk donors” and medically complex living donors.
- Evaluate the meanings of new studies regarding donor risk.
- Refine the current informed consent process in light of the evolving data.
Series category:
T3: Timely Topics in Transplantion
Donate
Donate
Career Center
Career Center
Patient Education
Patient Education
Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.